BIO U.S.: NYSE

    Bio-Rad Laboratories Inc. Cl A

    After Hours
    Last Updated: May 5, 2023 7:59 p.m. EDT Delayed quote

    $ 387.97

    2.73 0.71%
    After Hours Volume: 2.62K
    Close Chg Chg %
    $385.24 -77.37 -16.72%
    Advanced Charting
    Volume: 839.09K 65 Day Avg: 170.2K
    493% vs Avg
    373.07 Day Range 400.00
    344.63 52 Week Range 572.70

    Partner Center

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    BIO Overview

    Key Data

    • Open $400.00
    • Day Range 373.07 - 400.00
    • 52 Week Range 344.63 - 572.70
    • Market Cap $11.4B
    • Shares Outstanding 24.52M
    • Public Float 20.94M
    • Beta 0.85
    • Rev. per Employee $338.91K
    • P/E Ratio N/A
    • EPS -$6.54
    • Yield N/A
    • Dividend N/A
    • Ex-Dividend Date N/A
    • Short Interest 274.42K 04/14/23
    • % of Float Shorted 1.31%
    • Average Volume 170.2K


    5 Day
    • -15.13%
    1 Month
    • -18.03%
    3 Month
    • -17.98%
    • -8.38%
    1 Year
    • -19.58%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 6 Full Ratings

    Recent News

    Bio-Rad’s stock leads the S&P 500 decliners, as they suffer the biggest selloff in 36 years after disappointing results.

    Read full story

    Bio-Rad and German-based biotech Qiagen weighing latest tie-up in medical-diagnostic market

    Read full story

    5 stocks for the next 10 years — some picks are obvious, others not so much

    Read full story

    Dig a little, and you’ll find better stocks than the tech superstars, says Jefferies

    Read full story

    12 health-care stocks that will be winners because of coronavirus-led trends, according to Jefferies

    Read full story

    Jefferies Picks 20 Global Health-Care Winners for a Post-Pandemic World

    Read full story

    Five safe stocks for risk-blind millennials living in ‘uncertain’ times

    Read full story

    These life-science stocks provide biotech-like performance without the gyrations

    Bio-Rad Laboratories started at hold with $195 stock price target at Deutsche Bank

    SEC charges Bio-Rad Laboratories with bribery violations

    WASHINGTON (MarketWatch)--The Securities and Exchange Commission charged Bio-Rad Laboratories , a clinical diagnostic and life-science research company, with violating the Foreign Corrupt Practices Act. According to the SE...

    A tech hedge fund reveals latest picks


    Bio-Rad jumps 12% on Luminex deal

    BOSTON (MarketWatch) -- Shares of Bio-Rad Laboratories jumped 12% to $115.33 Tuesday after the company announced it has extended its marketing deal with research tool-maker Luminex Corp. . Under the deal, Bio-Rad will be ...

    Chuck Royce adds to small-cap positions

    Chuck Royce increased his Royce & Associates’ holdings in six small-cap companies and sold shares on a seventh, according to filings.

    Biotech analysts lukewarm on diagnostic stocks

    Biotech analysts are mixed on whether now is the time to move into stocks of diagnostic test-makers, even though many are trading at 52-week lows.

    Dow, S&P reach important downside targets

    Breaching Dow 10,000 is anything but positive, but the U.S. markets have reached important support points that could mark a significant intermediate-term floor.

    Dow, S&P reach significant downside targets

    Tuesday's analysis

    Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    on Benzinga.com

    Bio-Rad (BIO) Q1 Earnings Beat Estimates, Operating Margin Down

    on Zacks.com

    Bio-Rad Laboratories (BIO) Q1 Earnings and Revenues Beat Estimates

    on Zacks.com

    Recap: Bio-Rad Laboratories Q1 Earnings

    on Benzinga.com

    Can Cigna's (CI) Q1 Earnings Beat on Medical Customers Growth?

    on Zacks.com

    Here's Why You Should Retain Exact Sciences (EXAS) Stock Now

    on Zacks.com

    Embecta (EMBC) to Report Q2 Earnings: What's in Store?

    on Zacks.com

    Charles River (CRL) to Report Q1 Earnings: What's in Store?

    on Zacks.com

    Are Medical Stocks Lagging BioRad Laboratories (BIO) This Year?

    on Zacks.com

    Alcon (ALC) to Report Q1 Earnings: What's in the Cards?

    on Zacks.com

    What's in Store for DENTSPLY SIRONA (XRAY) in Q1 Earnings?

    on Zacks.com

    What to do with the Real Estate sector?

    on Zacks.com

    Quest Diagnostics (DGX) Q1 Earnings Top Estimates, Margins Down

    on Zacks.com

    Integra's (IART) Q1 Earnings Match Estimates, Margins Contract

    on Zacks.com

    Bio-Rad Laboratories (BIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

    on Zacks.com

    Edwards Lifesciences (EW) Q1 Earnings Top Estimates, '23 View Up

    on Zacks.com

    Lamb Weston and TTEC Holdings have been highlighted as Zacks Bull and Bear of the Day

    on Zacks.com

    The Zacks Analyst Blog Highlights BioRad Laboratories, Henry Schein, Insulet, Abbott and LabCorp

    on Zacks.com

    CVS Health (CVS) to Report Q1 Earnings: What's in the Cards?

    on Zacks.com

    Boston Scientific (BSX) Q1 Earnings Beat, 2023 View Raised

    on Zacks.com

    Bio-Rad Laboratories Inc. Cl A

    Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.


    Name Chg % Market Cap
    Roche Holding AG 0.60% CHF229.65B
    Roche Holding AG Akt 0.59% CHF229.65B
    Thermo Fisher Scientific Inc. 0.14% $210.74B
    Danaher Corp. 0.05% $178.9B
    Abbott Laboratories 0.36% $193.48B
    Merck & Co. Inc. 0.26% $298.74B
    Siemens AG 1.33% €118.7B
    Becton Dickinson & Co. 0.48% $72.04B
    Agilent Technologies Inc. -0.43% $39.42B
    bioMerieux S.A. 0.74% €11.59B